AdjuderaGet started

Supplier

OCTAPHARMA FRANCE

BOULOGNE-BILLANCOURT · FRA

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Awards

13

Total awarded

€175.9m

1 joint award(s) counted pro rata

Buyers

2

Sectors

1

Group: Octapharma GmbH(inferred)

Reg. 45132730800024

Contracts this supplier holds that are running out

All expiring contracts →

Awards

AwardedBuyerWinnerContract valuePublished
IG POLYVALENTE HUMAINE IV 100 MG / ML (10%) PAE - stabilisé au MALTOSEHospices Civils de LyonOCTAPHARMA FRANCE€6,993,88729 Apr 2025
IG POLYVALENTE HUMAINE IV 50 MG / ML (5%) PAE - stabilisé au MALTOSEHospices Civils de LyonOCTAPHARMA FRANCE€24,142,50029 Apr 2025
IG POLYVALENTE HUMAINE SOUS CUTANEE FORME INJECTABLE 165 MG / MLHospices Civils de LyonOCTAPHARMA FRANCE€59,774,41629 Apr 2025
ASSOCIATION FVIII HUMAIN ET F WILLEBRAND HUMAIN A DOSES EQUIVALENTESHospices Civils de LyonOCTAPHARMA FRANCE€2,840,50929 Apr 2025
ANTITHROMBINE HUMAINEHospices Civils de LyonOCTAPHARMA FRANCE€9,466,03829 Apr 2025
FIBRINOGENE HUMAINHospices Civils de LyonLFB BIOMEDICAMENTS, OCTAPHARMA FRANCE€69,652,46129 Apr 2025
COMPLEXE PROTHROMBINIQUE HUMAINHospices Civils de LyonOCTAPHARMA FRANCE€15,056,58829 Apr 2025
PLASMA THERAPEUTIQUEHospices Civils de LyonOCTAPHARMA FRANCE€4,103,82929 Apr 2025
FACTEUR VIII RECOMBINANT - SIMOCTOCOG ALFAHospices Civils de LyonOCTAPHARMA FRANCE€6,787,51929 Apr 2025
FACTEUR IX HUMAIN PLASMATIQUE sécurisation virale SD et nanofiltration à 20 nmHospices Civils de LyonOCTAPHARMA FRANCE€598,93029 Apr 2025
FACTEUR VIII HUMAIN PLASMATIQUEHospices Civils de LyonOCTAPHARMA FRANCE€11,052,37729 Apr 2025
IG POLYVALENTE HUMAINE IV 50 MG / ML (5%) ou 100 MG / ML (10%) PAE - stabilisé au MALTOSECH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOROCTAPHARMA FRANCE€36,54024 Apr 2025
IG POLYVALENTE HUMAINE SOUS CUTANEE FORME INJECTABLE 165 MG / MLCH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOROCTAPHARMA FRANCE€180,28624 Apr 2025